Your session is about to expire
← Back to Search
Video-Based HIV Test Information for Spanish-Speaking Latinos with HIV/AIDS
Phase 3
Waitlist Available
Led By Dr. Roland Merchant, MD, MPH, ScD
Research Sponsored by Rhode Island Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
18-64 years of age
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial will test whether a video on HIV and HIV tests is as effective as an in-person presentation with an HIV test counselor in delivering information to Spanish-speaking HIV test recipients.
Who is the study for?
This trial is for Spanish-speaking Latinos aged 18-64 who can consent to participate. It's not suitable for those with severe visual or hearing impairments, prisoners, the critically ill, intoxicated individuals, those treated for acute psychiatric illnesses, mentally incapacitated persons, or participants in HIV vaccine trials.Check my eligibility
What is being tested?
The study is testing if a video in Spanish about HIV and its testing methods is as effective as getting this information from an in-person counselor. Participants will receive either the video or live presentation.See study design
What are the potential side effects?
Since this trial involves informational videos and presentations rather than medical treatments, there are no direct side effects associated with the interventions being studied.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 64 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Effectiveness of an educational video regarding HIV and HIV testing for Spanish speaking Latinos
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Video PresentationExperimental Treatment1 Intervention
Participants will watch an HIV and HIV testing video
Group II: In Person CounselingActive Control1 Intervention
Participants will receive an in person HIV and HIV testing counseling session
Find a Location
Who is running the clinical trial?
Rhode Island HospitalLead Sponsor
257 Previous Clinical Trials
70,784 Total Patients Enrolled
8 Trials studying Acquired Immunodeficiency Syndrome
2,680 Patients Enrolled for Acquired Immunodeficiency Syndrome
Dr. Roland Merchant, MD, MPH, ScDPrincipal InvestigatorRhode Island Hospital
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have major issues with my sight or hearing.I am between 18 and 64 years old.I speak Spanish.I am currently receiving treatment for a sudden mental health issue.I am mentally capable of making my own decisions.
Research Study Groups:
This trial has the following groups:- Group 1: In Person Counseling
- Group 2: Video Presentation
Awards:
This trial has 2 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are we excluding elderly patients from this experiment?
"This particular clinical trial is only testing people aged 18 to 64. If you don't fit this age bracket, there are still 63 other trials testing minors and 183 trials testing seniors."
Answered by AI
Has the FDA cleared either Video or In-Person Presentation for use?
"There is some data to support the efficacy of a Video or In-Person Presentation, and it has received a score of 3 on the Power safety scale."
Answered by AI
Share this study with friends
Copy Link
Messenger